bioRxivCancer Biology
Uncertainties In Tumor Allele Frequencies Limit Power To Infer Evolutionary Pressures
Abstract
We read with great interest the paper by Williams, et. al.[1], who argued for neutral evolution in tumors by analyzing The Cancer Genome Atlas (TCGA) data. They supported this conclusion by showing high R2 values for fits to a neutral evolution model predicting M {propto} 1 / f, where M is the number of somatic mutations with allele frequency [≥] f. However, we believe a conclusion of neutrality must be treated cautiously, as high R2 values are consistent with many evolutionary models.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reply: Neutral tumor evolution?
Timon Heide, Luis Zapata, … Andrea Sottoriva·bioRxiv·May 10, 2018
- A pan-cancer signature of neutral tumor evolution
Andrea Sottoriva, Trevor Graham·bioRxiv·Feb 11, 2015
- On measuring selection in cancer from subclonal mutation frequencies
I. Bozic, C. Paterson, B. Waclaw·bioRxiv·Jan 24, 2019
- A unified simulation model for understanding the diversity of cancer evolution
A. Niida, T. Hasegawa, … S. Miyano·bioRxiv·Jan 28, 2020
- Signatures of neutral evolution in exponentially growing tumors: a theoretical perspective
H.-R. Tung, R. Durrett·bioRxiv·Jul 29, 2020
- Comparison of Tug-of-War Models Assuming Moran versus Branching Process Population Dynamics
K. N. Dinh, M. K. Kurpas, M. Kimmel·bioRxiv·Oct 20, 2023